Aug 19 (Reuters) - Biosyent Inc RX.V :
* Pharma acquires exclusive rights for Cysview(R) in Canada
* Says its subsidiary Biosyent pharma has signed an agreement with photocure
asa granting Biosyent the exclusive rights for cysview in Canada
* Says photocure will receive $1 million in milestone payments for rights to
cysview in Canada, which includes $650,000 upon signing of agreement
* Source text for Eikon ID:nCCN7Gph3j
* Further company coverage RX.V